Point72 Asset Management, L.P. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$3,035,895
-56.1%
3,097,852
-37.7%
0.01%
-57.1%
Q2 2023$6,915,250
+20.8%
4,975,000
+38.2%
0.02%
+16.7%
Q1 2023$5,724,000
-62.1%
3,600,000
+48.3%
0.02%
-64.7%
Q4 2022$15,120,210
-20.5%
2,427,000
-14.5%
0.05%
-32.9%
Q3 2022$19,017,000
+181.3%
2,838,300
+167.0%
0.08%
+162.1%
Q2 2022$6,761,000
-62.8%
1,063,096
+64.0%
0.03%
-65.9%
Q1 2021$18,182,000
+6257.3%
648,200
+13404.2%
0.08%
+4150.0%
Q4 2019$286,000
-98.1%
4,800
-98.9%
0.00%
-97.9%
Q3 2019$15,375,000
+395.0%
419,390
+528.1%
0.09%
+487.5%
Q2 2019$3,106,000
-64.4%
66,773
-69.2%
0.02%
-60.0%
Q1 2019$8,717,000
-61.3%
217,100
-57.2%
0.04%
-57.0%
Q3 2018$22,509,000
+57.7%
507,300
+39.3%
0.09%
+63.2%
Q2 2018$14,269,000
+685.7%
364,100
+372.9%
0.06%
+307.1%
Q3 2015$1,816,000
-42.7%
77,000
+98.5%
0.01%
-36.4%
Q2 2015$3,172,000
+632.6%
38,800
+262.6%
0.02%
+633.3%
Q4 2014$433,00010,7000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders